Sunday September 11th, 2016 07:56 Cannabis Science Issues Earnings Guidance for 2012 forecasted at $6,846,000 and potential increased to $65,740,000 in …

Cannabis Science, Inc. , a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to issue Sales Guidance and Outlook for 2012. There are three main markets for Cannabis Science Brand formulations for distribution, FDA approved prescriptions, OTC Non-psychoactive Neutroceuticals, and licensed dispensaries in legal Medical Marijuana states .

Related Blogs

    Comment Form

    Your name

    Your email

    Your URL